INDmoney
Cohance Lifesciences Ltd Q3 FY2025-2026 Results: Summary
Revenue | ₹550.71Cr |
Net Profits | ₹36.72Cr |
Net Profit Margins | 6.67% |
Cohance Lifesciences Ltd’s revenue fell -21.08% since last year same period to ₹550.71Cr in the Q3 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -3.58% fall in its revenue since last 3-months.
Cohance Lifesciences Ltd’s net profit fell -76.01% since last year same period to ₹36.72Cr in the Q3 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -50.43% fall in its net profits since last 3-months.
Cohance Lifesciences Ltd’s net profit margin fell -69.6% since last year same period to 6.67% in the Q3 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -48.59% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Cohance Lifesciences Ltd in Q3 results 2025?
The revenue for Cohance Lifesciences Ltd in the Q3 results 2025 was ₹550.71Cr.
What was the net profit for Cohance Lifesciences Ltd in Q3 results 2025?
The net profit for Cohance Lifesciences Ltd in the Q3 results 2025 was ₹36.72Cr.
What was the net profit margin for Cohance Lifesciences Ltd in Q3 results 2025?
The net profit margin for Cohance Lifesciences Ltd in the Q3 results 2025 was 6.67%.
What was the revenue for Cohance Lifesciences Ltd in Q3 results 2024?
The revenue for Cohance Lifesciences Ltd in the Q3 results 2024 was ₹697.79Cr.
What was the net profit for Cohance Lifesciences Ltd in Q3 results 2024?
The net profit for Cohance Lifesciences Ltd in the Q3 results 2024 was ₹153.07Cr.
What was the net profit margin for Cohance Lifesciences Ltd in Q3 results 2024?
The net profit margin for Cohance Lifesciences Ltd in the Q3 results 2024 was 21.94%.
